The Neurological Field Continues to Update

In recent years, there has been tremendous growth in new diagnostic information, pharmacological and neurosurgical treatments for neurological disease, as well as a greater understanding of brain function. Our news section informs you of ongoing topics with a potential worldwide influence. In addition to this section, we inform through our social media platforms to keep connect with our member more easier than before. 

 WFN FaceBook twitter linkedin round blue

Our subcategories on News include:

  • World Federation of Neurology News
    We inform you on our projects and activities, the journal updates, the WFN committee update and more...
  • Neurology News
    Update on interesting news and current activities with worldwide scope. From the history of neurology through the modern technology that shape neurology nowadays.

World Federation of Neurology News

iStock 612396272 WFN elections
Pinned

3 Mar 2026

The World Federation of Neurology announces positions up for election by the Council of Delegates in 2026

WFN is pleased to announce key leadership positions open for election by the Council of Delegates in 2026. We invite our member societies to nominate distinguished candidates who are dedicated to advancing neurology on a global scale.
IStock 2211117780 SyringeAmpule

12 Mar 2026

Journal of the Neurological Sciences issue 483 now available

The latest issue of JNS Vol. 483 is now available online
Wn Jan Feb26pdf

3 Mar 2026

World Neurology: January-February issue now available online

Welcome to World Neurology, a publication circulated and read by about 25,000 neurologists worldwide.

Neurology News

IStock 1218088615 Covid Prevalance

12 Mar 2026

Prevalence and trajectories of post-COVID-19 neuromuscular conditions

Systematic review and meta-analysis aimed to determine the long-term prevalence in COVID-19 survivors of fourteen specific NMDs and related symptoms.

IStock 2211117780 SyringeAmpule

12 Mar 2026

Journal of the Neurological Sciences issue 483 now available

Vol. 483, April 2026 now available

IStock 2239900173 Monoclonal Antibody

11 Mar 2026

α-synuclein monoclonal antibodies in Parkinson's disease: A failed promise or unmet potential?

A new review evaluates why monoclonal antibodies (mAbs) targeting α-synuclein have so far failed to demonstrate clinical benefit in Parkinson’s disease (PD), despite strong preclinical promise. Analysing data from five randomised controlled trials, the authors assess safety, pharmacokinetics, central nervous system exposure, and target engagement.

 

International Meetings & Events

6 Jul 2026 - 11 Jul 2026 The international Society for the history of neurosciences invites you to it's 30th meeting More details...
7 Jul 2026 - 11 Jul 2026 The ICNMD International Congress on Neuromuscular Diseases is organized on behalf of the Specialty Group on Neuromuscular Diseases (NMD) of the World Federation of Neurology (WFN). Since 2014, the... More details...
28 Oct 2026 - 29 Oct 2026 The World Federation of Neurology (WFN) Digital Neurology Updates (WNU 2026) will take place entire online 8-9 October 2026.The meeting offers a unique opportunity to access the latest global... More details...
21 Apr 2027 - 23 Apr 2027 EFIC Congress 2027 - Pain in Europe XV, 21-23 April 2027, Glasgow More details...